ACIU
Ac Immune Sa
NASDAQ · Biotechnology
$3.14
+0.18 (+6.08%)
Open$2.98
Previous Close$2.96
Day High$3.16
Day Low$2.96
52W High$29.08
52W Low$11.97
Volume—
Avg Volume783.5K
Market Cap310.68M
P/E Ratio—
EPS$0.04
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+657.3% upside
Current
$3.14
$3.14
Target
$23.78
$23.78
$21.93
$23.78 avg
$37.21
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 116.52M | 119.79M | 119.57M |
| Net Income | 209.8K | 199.8K | 200.3K |
| Profit Margin | 0.2% | 0.2% | 0.2% |
| EBITDA | 267.6K | 316.5K | 305.4K |
| Free Cash Flow | 236.0K | 248.3K | 178.6K |
| Rev Growth | +18.7% | -0.9% | +8.9% |
| Debt/Equity | 0.72 | 0.69 | 0.73 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |